Side-by-side comparison
NVS vs DHR — Side-by-side comparison
DHR screens cheaper on EV/FCF, DHR has the higher ROIC, DHR has grown revenue faster over five years, and DHR has the cleaner balance sheet by net debt / EBITDA.
NVS
Novartis AG
Price
$152.01
Market cap
$223.3B
Day %
N/A
DHR
Danaher Corp.
Price
$172.00
Market cap
$141.3B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
NVS implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
DHR implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
29.5x
FCF yield
3.7%
5Y rev CAGR
2.0%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for NVS.
Grade F
0
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for DHR.
Grade C
46
/ 100
Quality Radar0 – 20 per axis